Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tegmen Dehiscence and Audiologic Outcomes in the Middle Fossa Repair of Superior Semicircular Canal Dehiscence.

Journal of neurological surgery. Part B, Skull base·2026

Same author

Molecular and Clinicopathological Biomarkers Predicting Brain Metastasis in Triple-Negative Breast Cancer: A Systematic Review.

International journal of molecular sciences·2026

Same author

A Comprehensive Review of Immunotherapeutic Modalities in Glioblastoma: Mechanisms, Efficacy, and Safety Considerations <sup>†</sup>.

Cancers·2026

Same author

Dural Tears and Cerebrospinal Fluid Leak During and After the Middle Fossa Repair of Superior Canal Dehiscence Syndrome.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2025

Same author

Discovery and Tuning of RNA Editing Guides via High-Throughput Screening and Chemical Modification.

Chembiochem : a European journal of chemical biology·2025

Same author

Socioeconomic Factors Associate With Access but not Survival in Neurosurgical Brain Tumor Patients.

World neurosurgery·2025

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Interferon-gamma in brain tumor immunotherapy.

Ari Kane¹, Isaac Yang

¹Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA.

Neurosurgery Clinics of North America

|December 1, 2009

Summary

Interferon-gamma (IFNgamma) shows promise for treating brain tumors by enhancing immune response. Low levels in gliomas suggest therapeutic potential as an immunotherapy adjunct.

Area of Science:

Immunology
Oncology
Neuroscience

Background:

Interferon-gamma (IFNgamma) is a cytokine with therapeutic potential in cancer treatment.
IFNgamma activates genes that increase tumor immunogenicity, disrupt proliferation, and inhibit angiogenesis.
Malignant gliomas are characterized by low levels of IFNgamma production within the tumor microenvironment.

Purpose of the Study:

To review the literature on the role of IFNgamma in malignant glioma treatment.
To highlight the potential of IFNgamma as a therapeutic agent and immunotherapy adjunct for brain tumors.

Main Methods:

Literature review of published studies on IFNgamma and malignant gliomas.

Main Results:

IFNgamma has demonstrated potential in increasing tumor immunogenicity.

More Related Videos

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Related Experiment Videos

Last Updated: Jun 18, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

IFNgamma can disrupt tumor cell proliferation and inhibit angiogenesis.

Low endogenous IFNgamma levels are observed in glioma microenvironments.

Conclusions:

IFNgamma holds significant clinical potential for treating malignant gliomas.
IFNgamma may serve as a valuable adjunct to existing immunotherapeutic strategies for brain tumors.